Karen Buckland

2.4k total citations
24 papers, 851 citations indexed

About

Karen Buckland is a scholar working on Physiology, Genetics and Molecular Biology. According to data from OpenAlex, Karen Buckland has authored 24 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Karen Buckland's work include Virus-based gene therapy research (7 papers), Asthma and respiratory diseases (7 papers) and Lysosomal Storage Disorders Research (6 papers). Karen Buckland is often cited by papers focused on Virus-based gene therapy research (7 papers), Asthma and respiratory diseases (7 papers) and Lysosomal Storage Disorders Research (6 papers). Karen Buckland collaborates with scholars based in United Kingdom, United States and Germany. Karen Buckland's co-authors include Jennifer Kearley, Clare M. Lloyd, Dolores M. Conroy, Timothy J. Williams, Sara A. Mathie, Cory M. Hogaboam, Kristin J. Carpenter, H. Bobby Gaspar, Jane M. Schuh and Dominik Hartl and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Karen Buckland

23 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Buckland United Kingdom 12 483 375 220 166 136 24 851
Alfred D. Doyle United States 16 417 0.9× 359 1.0× 138 0.6× 145 0.9× 391 2.9× 35 986
Jean-Paul Papin France 12 424 0.9× 311 0.8× 143 0.7× 231 1.4× 111 0.8× 18 877
Rolf Haye Norway 14 314 0.7× 253 0.7× 240 1.1× 46 0.3× 198 1.5× 46 854
Margaret A. Horton United States 7 379 0.8× 511 1.4× 125 0.6× 101 0.6× 145 1.1× 8 801
Marijke De Veerman Belgium 6 492 1.0× 302 0.8× 132 0.6× 110 0.7× 37 0.3× 8 747
Wenming Peng Germany 18 464 1.0× 335 0.9× 439 2.0× 171 1.0× 50 0.4× 32 1.2k
Kota Kokubo Japan 13 300 0.6× 151 0.4× 75 0.3× 119 0.7× 61 0.4× 20 593
KI Matthaei Australia 7 289 0.6× 338 0.9× 134 0.6× 58 0.3× 120 0.9× 9 628
Danielle Karo‐Atar Israel 16 451 0.9× 168 0.4× 58 0.3× 127 0.8× 135 1.0× 24 714
Luz Roberts United States 11 244 0.5× 253 0.7× 90 0.4× 120 0.7× 41 0.3× 11 747

Countries citing papers authored by Karen Buckland

Since Specialization
Citations

This map shows the geographic impact of Karen Buckland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Buckland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Buckland more than expected).

Fields of papers citing papers by Karen Buckland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Buckland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Buckland. The network helps show where Karen Buckland may publish in the future.

Co-authorship network of co-authors of Karen Buckland

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Buckland. A scholar is included among the top collaborators of Karen Buckland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Buckland. Karen Buckland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qiling, Fang Zhang, Karen Buckland, et al.. (2024). Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease. Genes & Diseases. 12(3). 101445–101445. 1 indexed citations
2.
Jones, Simon, Rebecca Holley, Claire Booth, et al.. (2024). Clinical outcomes and sustained biochemical engraftment following ex-vivo autologous stem cell gene therapy for mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism. 141(2). 107905–107905. 2 indexed citations
3.
Ellison, Stuart, Karen Buckland, Spandan Kalra, et al.. (2024). Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy. Molecular Therapy — Methods & Clinical Development. 32(2). 101271–101271. 4 indexed citations
4.
Jones, Simon, Rebecca Holley, Claire Booth, et al.. (2023). Sustained biochemical engraftment and early clinical outcomes following autologous stem cell gene therapy for mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism. 138(2). 107171–107171. 2 indexed citations
5.
Vetharoy, Winston, Uimook Choi, Christine Rivat, et al.. (2021). Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47 phox -Deficient Chronic Granulomatous Disease. Human Gene Therapy. 32(17-18). 949–958. 4 indexed citations
6.
Jones, Simon, Adrian J. Thrasher, Claire Booth, et al.. (2021). Ex-vivo autologous stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: Update on phase I/II clinical trial. Molecular Genetics and Metabolism. 132(2). S56–S57. 2 indexed citations
7.
Wynn, Robert, Brian Bigger, Adrian J. Thrasher, et al.. (2020). Ex-Vivo Autologous Stem Cell Gene Therapy Clinical Trial for Mucopolysaccharidosis Type IIIA: Trial in Progress - NCT04201405. Blood. 136(Supplement 1). 15–16. 6 indexed citations
8.
Church, Heather J., Ceri Jones, Karen Buckland, et al.. (2020). Case report of the first patient treated with ex-vivo autologous haematopoietic stem cell gene therapy transplant in mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism. 129(2). S90–S90. 4 indexed citations
9.
Schott, Juliane W., Diego León‐Rico, Karen Buckland, et al.. (2019). Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application. Molecular Therapy — Methods & Clinical Development. 14. 134–147. 37 indexed citations
10.
Poletti, Valentina, Sabine Charrier, Samia Martin, et al.. (2016). Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1). Blood. 128(22). 4705–4705. 1 indexed citations
11.
Buckland, Karen & H. Bobby Gaspar. (2014). Gene and cell therapy for children — New medicines, new challenges?. Advanced Drug Delivery Reviews. 73. 162–169. 32 indexed citations
12.
Bacchelli, Chiara, Karen Buckland, Sylvie Buckridge, et al.. (2011). The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. Journal of Allergy and Clinical Immunology. 127(5). 1253–1259.e13. 23 indexed citations
13.
Campbell, John D., Karen Buckland, Sarah J. McMillan, et al.. (2009). Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression. The Journal of Experimental Medicine. 206(7). 1535–1547. 176 indexed citations
14.
Kearley, Jennifer, Karen Buckland, Sara A. Mathie, & Clare M. Lloyd. (2009). Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2–IL-33 Pathway. American Journal of Respiratory and Critical Care Medicine. 179(9). 772–781. 199 indexed citations
15.
Buckland, Karen, et al.. (2008). Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflammation Research. 57(8). 379–387. 24 indexed citations
16.
Buckland, Karen, et al.. (2007). Remission of chronic fungal asthma in the absence of CCR8. Journal of Allergy and Clinical Immunology. 119(4). 997–1004. 17 indexed citations
17.
Hartl, Dominik, Karen Buckland, & Cory M. Hogaboam. (2006). Chemokines in Allergic Aspergillosis - From Animal Models to Human Lung Diseases. Inflammation & Allergy - Drug Targets. 5(4). 219–228. 33 indexed citations
18.
Hogaboam, Cory M., Kristin J. Carpenter, Jane M. Schuh, & Karen Buckland. (2005). Aspergillusand asthma – any link?. Medical Mycology. 43(s1). 197–202. 43 indexed citations
19.
Hogaboam, Cory M., et al.. (2005). The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. Pharmacology & Therapeutics. 107(3). 314–328. 24 indexed citations
20.
Buckland, Karen, Timothy J. Williams, & Dolores M. Conroy. (2003). Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. British Journal of Pharmacology. 140(6). 1117–1127. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfred D. Doyle Breakdown of academic impact, for papers by Jean-Paul Papin Breakdown of academic impact, for papers by Rolf Haye Breakdown of academic impact, for papers by Margaret A. Horton Breakdown of academic impact, for papers by Marijke De Veerman Breakdown of academic impact, for papers by Wenming Peng Breakdown of academic impact, for papers by Kota Kokubo Breakdown of academic impact, for papers by KI Matthaei Breakdown of academic impact, for papers by Danielle Karo‐Atar Breakdown of academic impact, for papers by Luz Roberts
Rankless by CCL
2026